ICU Delirium - Prevention and Management

Key Points

• Screen for delirium routinely because hypoactive delirium is easily missed.
• Delirium is a syndrome requiring a search for infection, hypoxia, metabolic disturbance, withdrawal, pain, neurologic disease, and medication effects.
• Use the lightest safe sedation and avoid routine benzodiazepine sedation when alternatives are appropriate.
• Early mobility, sleep promotion, sensory aids, orientation, family engagement, and removal of unnecessary devices are core treatment.
• Antipsychotics are not routine disease-modifying therapy for ICU delirium.
• Dangerous agitation can justify short-term medication while the underlying cause is treated.
• New delirium should be documented and handed off because cognitive effects can persist after ICU discharge.

Algorithm

1. Assess arousal and screen with CAM-ICU or ICDSC.
2. Search immediately for hypoxemia, hypercapnia, shock, sepsis, glucose or electrolyte problems, urinary retention, constipation, withdrawal, pain, seizure, or structural neurologic disease.
3. Review sedatives, opioids, anticholinergics, corticosteroids, and other deliriogenic medications.
4. Set a light sedation target and coordinate awakening and breathing trials when appropriate.
5. Implement mobility, orientation, hearing and vision aids, daylight exposure, nighttime sleep protection, and family engagement.
6. Use syndrome-specific treatment for withdrawal or another identified cause.
7. Reserve antipsychotics or dexmedetomidine for selected severe agitation or extubation-limiting situations.
8. Reassess daily and discontinue temporary psychoactive medications before transfer when possible.

Clinical Synopsis & Reasoning

Delirium in the ICU is an acute change in attention and cognition with a fluctuating course. Hyperactive agitation is easy to recognize, but hypoactive delirium is common and can be missed unless the team screens systematically. A patient who is quiet, inattentive, slow to respond, or newly disoriented may have clinically important delirium even without pulling at lines or attempting to leave the bed.

The diagnosis is clinical and should be made with a validated instrument such as CAM-ICU or ICDSC after assessing arousal. Delirium should not be attributed to the ICU environment until dangerous reversible causes are considered. Hypoxemia, hypercapnia, sepsis, shock, stroke, seizure, intracranial bleeding, hypoglycemia, electrolyte disorders, hepatic or uremic encephalopathy, urinary retention, constipation, pain, intoxication, and alcohol or sedative withdrawal are common contributors. Medication review is essential, especially benzodiazepines, anticholinergics, high opioid exposure, corticosteroids in susceptible patients, and polypharmacy.

The 2025 SCCM PADIS focused update reinforces nonpharmacologic care and notes insufficient evidence for routine antipsychotic treatment of delirium. The practical goal is to reduce the drivers of brain dysfunction rather than sedate the behavior. Sleep fragmentation, immobility, sensory deprivation, restraints, unnecessary lines, and lack of daylight or orientation all perpetuate delirium.

Treatment Strategy & Disposition

Treat the precipitating cause, correct hypoxemia and metabolic derangements, drain a painful bladder, address constipation, and treat withdrawal with the appropriate syndrome-specific regimen. Review every sedative and analgesic. Target the lightest safe sedation, coordinate spontaneous awakening and breathing trials in ventilated patients, and avoid benzodiazepines for routine sedation unless there is a specific indication such as alcohol withdrawal or seizures.

Use the ICU Liberation or ABCDEF approach: assess pain, conduct awakening and breathing trials, choose appropriate analgesia and sedation, assess and manage delirium, mobilize early, and engage family. Provide eyeglasses and hearing aids, visible clocks and calendars, daytime light, quiet nighttime routines, repeated orientation, and familiar voices. Remove unnecessary catheters and restraints when possible. The 2025 PADIS update conditionally supports enhanced mobilization and rehabilitation and also supports melatonin in selected adult ICU patients, though it is not a cure for established delirium.

Antipsychotics do not shorten delirium reliably and should not be prescribed reflexively. A short course may be considered when severe agitation creates immediate risk to the patient or staff and nonpharmacologic measures are insufficient, with attention to QT interval, extrapyramidal effects, and drug interactions. Dexmedetomidine can be useful in selected mechanically ventilated patients when agitation prevents extubation or when light cooperative sedation is desired. Reassess daily and stop temporary psychoactive drugs as soon as the indication resolves.

Epidemiology / Risk Factors

• Delirium is common in mechanically ventilated and severely ill ICU patients.
• Advanced age, baseline cognitive impairment, severe illness, mechanical ventilation, benzodiazepine exposure, and immobility increase risk.
• Hypoactive delirium is common and often underdiagnosed.
• Delirium duration is associated with worse short- and long-term outcomes.

Investigations

Delirium Bundle Elements

Pharmacology

Prognosis / Complications

• Delirium often improves as illness and medication burden resolve, but recovery can take days to weeks.
• Longer delirium duration is associated with increased mortality, longer hospitalization, and cognitive impairment after critical illness.
• Reversible contributors such as urinary retention or medication toxicity can improve rapidly once corrected.
• Persistent cognitive, sleep, mood, or functional symptoms after ICU discharge may require structured follow-up.

Patient Education / Counseling

• Tell families that delirium is an acute brain dysfunction caused by illness and treatment, not simply confusion or poor cooperation.
• Encourage calm reorientation, familiar conversation, glasses and hearing aids, and a day-night routine.
• Explain that hallucinations and frightening memories may occur and can persist after discharge.
• Advise survivors to seek follow-up for persistent memory, mood, sleep, or functional problems.

Notes

Delirium is best treated as a vital sign of brain dysfunction. A new positive screen should trigger the same disciplined search for cause that hypotension or hypoxemia would. Simply suppressing agitation can make the patient appear calmer while worsening the underlying problem or delaying recognition of deterioration.

The 2025 PADIS focused update adds new evidence around sedation, mobility, and sleep. It conditionally favors dexmedetomidine over propofol when light sedation and delirium-related considerations are priorities, but drug choice still depends on hemodynamics, ventilation, and the specific clinical goal.

References

1. SCCM 2025 PADIS Focused Update — Link
2. SCCM ICU Liberation ABCDEF Bundle — Link